On February 11, 2025 Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, reported that company management will participate in the following investor conferences (Press release, Tyra Biosciences, FEB 11, 2025, View Source [SID1234650179]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Oppenheimer 35th Annual Healthcare Life Sciences Conference, February 11-12, 2025
Format: Fireside chat and one-on-one investor meetings
Presentation Date/Time: Wednesday, February 12, 2025, at 2:00 PM ET
Location: Virtual
TD Cowen 45th Annual Healthcare Conference, March 3-5, 2025
Format: Fireside chat and one-on-one investor meetings
Presentation Date/Time: Monday, March 3, 2025, at 9:50 AM ET
Location: Boston
Jefferies Biotech on the Beach Summit, March 11-12, 2025
Format: One-on-one investor meetings
Location: Miami
Barclays 27th Annual Global Healthcare Conference, March 11-13, 2025
Format: Fireside chat and one-on-one investor meetings
Presentation Date/Time: Wednesday, March 12, 2025, at 8:30 AM ET
Location: Miami

A live and archived webcast of the fireside chats will be available via the For Investors page on the Investor section of the TYRA website.